Baljit Kaur

Baljit Kaur practices at Nassau University Medical Center in East Meadow, New York, part of NuHealth.

Baljit Kaur's NPI, 1700330628, was assigned on August 9, 2016. Baljit Kaur graduated from Government Medical College Patiala in 2012. Baljit Kaur holds New York license 304897.

Baljit Kaur's primary practice is Nassau University Medical Center, at 2201 Hempstead Turnpike, East Meadow, NY 11554 in Nassau County. The practice phone is (516) 572-0123.

Baljit Kaur's primary practice is Nassau University Medical Center in East Meadow, New York, part of NuHealth. The medical group on file is Nassau University Medical Center (NUMC), Department of Psychiatry and Behavioral Sciences. Dmand AI also links Baljit Kaur to 1 more hospital, 3 medical groups, 1 group practice or clinic and 1 home health agency, each named with a free account. Baljit Kaur's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Baljit Kaur practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Baljit Kaur's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Baljit Kaur's licenses on file in 2 states: New York and New Jersey.

CMS data shows 942 Medicare services from Baljit Kaur across 5 procedure codes in 2024, for 266 Medicare patients. Medicare paid $67,409 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 266 Medicare patients who saw Baljit Kaur in 2024. The largest group is 75 to 84, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Baljit Kaur's median patient age at 50, with 50% women.

In 2024, Baljit Kaur wrote 108 Medicare Part D claims. 97% of them were for generic drugs. CMS names the drug for 97 of them, across 7 drugs with 11 or more claims each, at $1,226 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Baljit Kaur accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Baljit Kaur, published from 2021 to 2023. Baljit Kaur's most frequent co-author is Timur Mitin, MD, PhD.

CMS Open Payments shows 2 general payments to Baljit Kaur from 2 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $15.

Baljit Kaur graduated from Government Medical College Patiala in 2012.